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SUMMARY – Spinal metastatic disease is a rather common occurrence and defi nitely warrants 
attention and treatment due to the high likelihood of leaving cancer patients severely disabled in their 
fi nal months of life. Recent developments in the understanding of the behavior of diff erent tumor 
types, as well as advances in surgical treatment, are allowing for the evolution of treatment algorithms, 
especially when surgical treatment is to be considered. Th is paper gives an overview of the decision-
making process and the array of surgical options currently available.
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Introduction
Th e purpose of this article is to give an overview of 
the approach to treating spinal column metastases in 
cancer patients. Th is is a complex fi eld which requires 
thorough understanding of all treatment modalities 
available and decisions must be guided by a rational 
framework based on a number of parameters.
Spinal metastases are by no means an uncommon 
phenomenon, as virtually any malignant tumor type 
has the potential to metastasize to bone, with the spine 
being the predominant bony site1.
Since some form of bony metastasis is almost to be 
expected in advanced stage malignant disease, it may 
be discovered through targeted screening using any of 
a number of diagnostic modalities (CT/PET-CT, 
MRI, bone scan). However, in case of an unknown pri-
mary tumor, symptoms from the metastases may be 
the fi rst signs of any illness. In this case, there are many 
‘red fl ags’ which have been described to help guide the 
need for spinal malignancy screening2. Although none 
of these red fl ags except for prior history of cancer car-
ried much weight as a warning sign, careful use of 
combinations of red fl ags can be of benefi t (age over 
50, pain not relieved after a month of rest, thoracic 
pain which is worse at night, unexplained weight loss, 
generally poor state of health, etc.)2.
It must be borne in mind that the goals of treat-
ment of spinal metastases diff er from the goals of 
treating primary tumors considering that treatment is 
seldom curative. In metastatic cases, surgeons strive to 
improve the overall quality of life in a patient other-
wise undergoing treatment for their primary tumor by 
decreasing pain, relieving neurological impairment, 
providing stability, and increasing patient indepen-
dence1.
Non-surgical treatment includes chemotherapy, 
 radiotherapy, hormonal therapy (for example, in breast 
and prostate tumors), angiography and embolization 
(in highly vascular metastases, including renal cell, 
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thyroid, melanoma, giant cell tumors, and hepatocel-
lular carcinomas), and symptom management. Radio-
therapy is often used with or without surgery and must 
be considered where histopathology of the primary 
tumor is one of known radiosensitivity (breast, pros-
tate, Wilm’s tumor, Ewing’s sarcoma, lymphoma, sem-
inoma, multiple myeloma, medulloblastoma, etc.), al-
though even in relatively radioresistant histologies 







Neurologic symptom and degree of bone destruction
Minimal neurology
Involvement of bone without collapse or instability and minimal neurology
Major neurologic impairment without spinal instability
Vertebral collapse and instability, without major neurologic impairment





Chemotherapy, hormonal therapy, radiotherapy
Radiotherapy with corticosteroid treatment
Surgery
Table 2. Revised Tokuhashi scoring system for treatment decision guidance based on expected outcome
Characteristic Score
General condition (performance status)
Poor (PS 10 ~ 40%)
Moderate (PS 50 ~ 70%)

























Primary site of the cancer
Lung, osteosarcoma, stomach, bladder, esophagus, pancreas












Complete (Frankel A, B)





Criteria of predicted prognosis: Total Score 















•  No metastases to the major 
internal organs
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(lung, renal, etc.) pain relief may be achievable3. Che-
motherapy has its role in chemosensitive tumors (lym-
phomas, Ewing’s, Wilm’s, rhabdomyosarcoma, terato-
ma, etc.).
Surgery can also have an important role in cases in 
which it is deemed feasible. Surgical treatment is, of 
course, not without its own risks to the patient and 
benefi ts of the selected treatment modality must al-
ways outweigh the risks to the patient. It has long been 
held as general consensus that minimal life expectancy 
of 3 to 6 months is the minimum requirement for con-
sidering a major surgery4. However, in shorter life ex-
pectancies, palliative surgical procedures (kyphoplasty, 
vertebroplasty, placement of a morphine pump) could 
be benefi cial notwithstanding the morbidity they pres-
ent5. In order to help systematize the decision-making 
process, several classifi cation scoring systems, as well 
as treatment algorithms have been developed which 
take into account parameters such as primary tumor 
histopathology, severity of impairment, overall wellbe-
ing, and likelihood to receive any benefi t from surgery.
Harrington has proposed the treatment algorithm 
shown in Table 1 solely based on the amount of verte-
bral destruction and instability6,7. Enneking, Tomita, 
and Weinstein/Boriani/Biagini describe patterns of 
tumor spread throughout a vertebra8. Th e Tokuhashi 
scoring system shown in Table 2 is one of the com-
monly used tools for treatment guidance9,10. It takes 
into account the general state of the patient as evalu-
ated by the Karnofsky performance score (shown in 
Table 3), the number of local (spinal), extraspinal and 
visceral metastases, tumor histology, and neurological 
status according to Frankel (summarized in Table 4). 
However, the modifi ed Bauer score has been shown to 
be a simpler system because it considers only the pa-
rameters which have been shown to mostly infl uence 
prognosis (shown in Table 5)11. It is reasonable to con-
sider combining several systems in order to synthesize 
fi nal decision. For example, by using the Harrington 
principles, the Spinal Instability Neoplastic Score 
(SINS) (Table 6), Tomita type12, and Tokuhashi score 
together, one can more confi dently determine the best 
course of action for a given patient.
According to histologic subtypes, tumors can be 
classifi ed into (1) slow growing (breast, prostate, car-
cinoid, thyroid), (2) moderately growing (kidney, uter-
us), and (3) rapidly growing (lung, liver, stomach, 
esophagus, pancreas, sarcomas, bladder) tumors13. 














Normal; no complaints; no evidence of disease
Able to carry on normal activity; minor signs 
or symptoms of disease
Normal activity with eff ort; some signs or 
synptoms of disease
Cares for self; unable to carry on normal 
activity or to do active work
Requires occasional assistance, but is able to 
care for most of his personal needs
Requires considerable assistance and frequent 
medical care
Disabled; requires special care and assistance
Severely disabled; hospital admission is 
indicated although death not imminent
Very sick; hospital admission necessary; active 
supportive treatment necessary
Moribund; fatal processes progressing rapidly
Dead
Table 4. Frankel classifi cation of patients according to 
initial neurological function
A –  Absence of motor or sensory function below 
the level of the lesion
B –  Absence of motor function, but with some 
degree of sensitivity preserved below the level 
of the lesion
C –  Some degree of motor function but without 
practical usefulness
D –  Useful motor function below the level 
of the lesion
E –  Normal sensory and motor function, although 
there may be some abnormality of refl exes
Table 5. Modifi ed Bauer score
Score 1 point for each of the following positive 
prognostic factors:
•  No visceral metastases
•  No lung cancer
•  Primary tumor * breast, kidney, lymphoma, 
multiple myeloma
•  One solitary skeletal metastasis
Suggestions for treatment
• Score 0–1: Supportive care, no surgery
• Score 2: Short term palliation, dorsal surgery
• Score 3–4:  Middle term local control, 
ventral-dorsal surgery
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Knowing the biological behavior of certain subtypes 
can give one a general sense of urgency required for the 
overall workup and treatment duration. In all cases, it 
is prudent to engage a team of spinal surgeons as soon 
as possible to optimize outcome when surgical inter-
vention is feasible.
Surgical Techniques
Before the advent of surgical treatment for meta-
static spine disease, the standard treatment options 
were radiotherapy and corticosteroid application. Sur-
gical treatment for spinal metastases fi rst received con-
fi rmation of effi  cacy by Patchell et al., who were the 
fi rst to demonstrate in a randomized prospective study 
that patients that were surgically decompressed clearly 
showed better results than those undergoing only pal-
liative radiotherapy without decompression14. Since 
then, various criteria have been developed for the se-
lection of patients that would benefi t most from surgi-
cal treatment9,13. Th e degree of spinal cord compres-
sion has been better defi ned15, a framework has been 
established for considering spinal instability brought 
about by malignant disease16, and most recently, the 
required extent of treatment has been better defi ned17. 
Th us, spinal surgery has established its place within 
the complex, multidisciplinary and palliative approach 
to patients with spinal metastatic disease. Th e goals of 
surgical treatment of spinal metastases are local con-
trol of tumor size, pain reduction, maintaining motor 
function and sphincter control, prevention of defor-
mity, and upgrading the quality of remaining lifetime. 
However, before deciding on surgical treatment of 
spinal metastatic disease, it is imperative to know the 
histology of the specifi c tumor and the overall spread 
of the malignant disease, as these are the most impor-
tant predictors of survival. Th erefore, biopsy should be 
the fi rst step to surgical treatment. Biopsy can be per-
formed percutaneously by needle in local or general 
anesthesia and under control of an image intensifi er or 
by computerized tomography (Fig. 1). If the result of 
such a biopsy should turn out negative for malignant 
cells and strong suspicion of malignancy remains, then 
open biopsy should be the next step.
Upon deciding on the need of surgical treatment, it 
may be necessary to perform preoperative emboliza-
tion of the tumor in order to reduce intraoperative 
bleeding. Th is is especially important for histologic 
types which are prone to excess bleeding (for example, 
renal cell or thyroid cancer), as seen in Figure 2.
Th e spinal surgeon has an array of treatment op-
tions that diff er in invasiveness and how radical the 
tumor resection should be17. Th e most radical opera-
tion is en bloc resection of a tumor according to the 
principles of treatment of primary spinal tumors12. 
Th ey are divided into 3 types of radical resections: ver-
tebrectomy, sagittal resection of a vertebra, and total 
resection of posterior elements8. Th e indication for 
such a procedure would be a controllable histologic 
type of tumor, the presence of a metastasis that is tech-
nically resectable with a surrounding layer of healthy 
tissue, the lack of other distant metastases, and a gen-
erally good overall state of the patient (Fig. 3).
Table 6. Th e Spinal Instability Neoplastic Score (SINS): a 





Location Junctional (occiput-C2, 
C7-T2, T11-L1, L5-S1)
3





















No collapse with 50% body 
involved
1







None of the above 0
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Th e complex anatomy of the surrounding struc-
tures and the central placement of neural elements 
within the spinal canal pose a unique challenge to per-
forming radical resections of spinal tumors. Th at is 
why it is usually only possible to perform a marginal or 
intralesional resection, or reduction of the tumor along 
Fig. 1. Computerized tomography guided percutaneous transpedicular placement of a biopsy needle 
in a thoracic vertebral body.
Fig. 2. Computerized tomography images in 3 planes of a highly vascularized thyroid cancer spinal metastasis, 
followed by pre- and post-embolization fl uoroscopy images of the same case. Note the instillation of contrast medium 
in the pre-embolization image, followed by complete blockage of the feeding vessel in the post-embolization image.
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with stabilization of the spinal column. Th ese proce-
dures are less radical than en bloc resections, although 
they may yield virtually identical results if stereotactic 
radiosurgery (which has signifi cantly altered the treat-
ment approach to patients with spinal metastases) is 
additionally performed19.
Th e goal of modern surgery in metastatic spine dis-
ease is to ensure suffi  cient distancing of the tumor from 
the spinal cord (separational surgery) and to provide 
stable fi xation of the spinal column to allow for safe ap-
plication of radiotherapy on the whole tumor volume.
In the case of spinal instability and great pain, which 
would hinder upright posture and/or ambulation in the 
patient, there are several ways in which stabilization can 
be achieved. Stabilization is indicated when there is a 
clear risk of instability according to the SINS score, re-
Fig. 3. Magnetic resonance images of a solitary Th 12 metastasis of a primary breast cancer, 
confi ned to the vertebral body with slight bulging into the epidural space with immediate 
postoperative plain fi lm radiographs after en bloc vertebrectomy of the above Th 12 metastasis 
with anterior support with a graft-fi lled mesh cage and posterior transpedicular fi xation.
Fig. 4. Plain fi lm radiographic demonstration of typical examples of combined 
anterior and posterior stabilization using interbody cages fi lled with graft material 
anteriorly and lateral mass screws and rods, as in the above cervical segments.
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Fig. 5. Magnetic resonance image of multilevel metastatic involvement of the spinal column with corresponding 
intraoperative fl uoroscopic images of percutaneous vertebral body augmentation (vertebroplasty) in the same patient.
Fig. 6. Postoperative view of the skin incisions after minimally invasive (percutaneous) fi xation of the lumbar spine 
with corresponding intraoperative fl uoroscopic sagittal and coronal views.
gardless of histologic tumor type and overall predicted 
survival, provided that the general state of the patient 
allows for surgery to be performed, some examples of 
which can be seen in Figure 414. Stabilization methods 
include open anterior and posterior stabilization, percu-
taneous stabilization methods, and vertebroplasty or 
kyphoplasty20. Minimally invasive methods for stabili-
zation of the vertebral body are particularly convenient 
as palliative techniques for patients who otherwise 
would not be candidates for radical surgery, such as pa-
tients with multilevel involvement (Fig. 5)21. Percutane-
ous stabilization of the spine is indicated in patients in 
whom there is clear instability without signifi cant spinal 
cord compression (Fig. 6)22. 
In the case that the expected remaining lifespan of 
the patient is under 3 months and there are multiple 
metastatic changes along the spinal column and un-
bearable pain that is unresponsive to high doses of 
 opioid analgesics, it is recommended to install an in-
trathecal opioid pump to be able to control pain with 
much lower doses of opioids and fewer complications 
(Fig. 7).
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Fig. 7. Placement of an intrathecal pump device for administration of opioids. 
Conclusion
Patients with spine metastases frequently present 
with complex diagnostic and therapeutic challenges 
requiring an integrated multi-step approach and mul-
tidisciplinary care, including a team of surgeons and 
oncologists. In managing these patients, every eff ort 
should be made to provide an early diagnosis and ap-
propriate treatment for preservation of neurological 
function and quality of remaining life. Unfortunately, 
diagnosis is frequently not established until signifi cant 
neurological defi cit is present, by which time function-
al recovery may be unlikely. Newer surgical techniques 
that address decompression, spinal stabilization, with 
or without tumor resection, and minimally invasive 
pain relieving strategies must be taken into consider-
ation in surgical candidates. Studies have shown clear 
benefi t of surgical management in terms of maintain-
ing ambulation and sphincter control, as well as in 
 providing pain relief and prolonging patient inde-
pendence. Although surgical intervention will not de-
crease mortality, it should nonetheless be strongly con-
sidered in patients that fulfi ll the established criteria 
for a reasonable outcome.
References
 1. Lee CS, Jung CH. Metastatic spinal tumor. Asian Spine J. 2012 
Mar;6(1):71-87. doi: 10.4184/asj.2012.6.1.71
 2. Henschke N, Maher CG, Ostelo RW, De Vet HC, Macaskill P, 
Irwig L. Red fl ags to screen for malignancy in patients with 
low-back pain. Cochrane Database Syst Rev. [Research Sup-
port, Non-U.S. Gov’t Review]. 2013(2):CD008686. doi: 
10.1002/14651858.CD008686.pub2
 3. Khmelevsky EV, Bychkova NM. [Radiosensitivity of bone me-
tastases from tumors in diff erent primary sites]. Vopr Onkol. 
[Randomized Controlled Trial]. 2015;61(1):77-84.
 4.  Wise JJ, Fischgrund JS, Herkowitz HN, Montgomery D, Kurz 
LT. Complication, survival rates, and risk factors of surgery for 
metastatic disease of the spine. Spine (Phila Pa 1976). 1999 Sep 
15;24(18):1943-51.
 5.  Bašić Kes V, Bašić-Jukić N, Kes P, Demarin V, Labar B. [Neu-
rologic sequelae of bone changes in multiple myeloma and its 
therapy]. Acta Med Croatica. [Review]. 2002;56(3):103-7. (in 
Croatian)
 6.  Harrington KD. Metastatic disease of the spine. J Bone Joint 
Surg Am. 1986 Sep;68(7):1110-5.
 7.  Harrington KD. Anterior decompression and stabilization of 
the spine as a treatment for vertebral collapse and spinal cord 
compression from metastatic malignancy. Clin Orthop Relat 
Res. 1988 Aug(233):177-97.
 8.  Boriani S, Weinstein JN, Biagini R. Primary bone tumors of 
the spine. Terminology and surgical staging. Spine (Phila Pa 
1976). [Research Support, Non-U.S. Gov›t Review]. 1997 May 
1;22(9):1036-44.
 9.  Tokuhashi Y, Matsuzaki H, Oda H, Oshima M, Ryu J. A re-
vised scoring system for preoperative evaluation of metastatic 
spine tumor prognosis. Spine (Phila Pa 1976). [Comparative 
Study Evaluation Studies]. 2005 Oct 1;30(19):2186-91.
10.  Quraishi NA, Manoharan SR, Arealis G, Khurana A, Elsayed 
S, Edwards KL, et al. Accuracy of the revised Tokuhashi score 
in predicting survival in patients with metastatic spinal cord 
compression (MSCC). Eur Spine J. 2013 Mar;22 Suppl 1:S21-
6. doi: 10.1007/s00586-012-2649-5
11.  Leithner A, Radl R, Gruber G, Hochegger M, Leithner K, 
Welkerling H, et al. Predictive value of seven preoperative 
prognostic scoring systems for spinal metastases. Eur Spine J. 
2008 Nov;17(11):1488-95. doi: 10.1007/s00586-008-0763-1
12.  Tomita K, Kawahara N, Baba H, Tsuchiya H, Nagata S, To-
ribatake Y. Total en bloc spondylectomy for solitary spinal me-
tastases. Int Orthop. 1994 Oct;18(5):291-8. 
13.  Tomita K, Kawahara N, Kobayashi T, Yoshida A, Murakami H, 
Akamaru T. Surgical strategy for spinal metastases. Spine (Ph-
ila Pa 1976). [Case Reports]. 2001 Feb 1;26(3):298-306.
14.  Patchell RA, Tibbs PA, Regine WF, Payne R, Saris S, Krys-
cio RJ, et al. Direct decompressive surgical resection in the 
M. Franić et al. Surgery for spinal metastases
482 Acta Clin Croat, Vol. 55, No. 3, 2016
treatment of spinal cord compression caused by metastatic 
 cancer: a randomised trial. Lancet. [Clinical Trial Multicen-
ter Study Randomized Controlled Trial Research Support, 
N.I.H., Extramural Research Support, U.S. Gov’t, P.H.S.]. 
2005 Aug 20-26;366(9486):643-8. doi: 10.1016/S0140-6736
(05)66954-1
15.  Bilsky MH, Laufer I, Fourney DR, Groff  M, Schmidt MH, 
Varga PP, et al. Reliability analysis of the epidural spinal cord 
compression scale. J Neurosurg Spine. [Research Support, 
Non-U.S. Gov’t Validation Studies]. 2010 Sep;13(3):324-8. 
doi: 10.3171/2010.3.SPINE09459
16.  Fisher CG, Dipaola CP, Ryken TC, Bilsky MH, Shaff rey CI, 
Berven SH, et al. A novel classifi cation system for spinal insta-
bility in neoplastic disease: an evidence-based approach and 
expert consensus from the Spine Oncology Study Group. 
Spine (Phila Pa 1976). [Case Reports Review]. 2010 Oct 
15;35(22):E1221-9. doi: 10.1097/BRS.0b013e3181e16ae2
17. Laufer I, Rubin DG, Lis E, Cox BW, Stubblefi eld MD, Ya-
mada Y, et al. Th e NOMS framework: approach to the treat-
ment of spinal metastatic tumors. Oncologist. 2013 Jun;
18(6):744-51. doi: 10.1634/theoncologist.2012-0293
18. Kaloostian PE, Zadnik PL, Etame AB, Vrionis FD, Gokaslan 
ZL, Sciubba DM. Surgical management of primary and meta-
static spinal tumors. Cancer Control. [Research Support, Non-
U.S. Gov‘t Review]. 2014 Apr;21(2):133-9.
19.  Moulding HD, Elder JB, Lis E, Lovelock DM, Zhang Z, Ya-
mada Y, et al. Local disease control after decompressive surgery 
and adjuvant high-dose single-fraction radiosurgery for spine 
metastases. J Neurosurg Spine. 2010 Jul;13(1):87-93. doi: 
10.3171/2010.3.SPINE09639
20.  Salapura V, Jeromel M. Minimally invasive (percutaneous) 
treatment of metastatic spinal and extraspinal disease – a re-
view. Acta Clin Croat. [Review]. 2014 Mar;53(1):44-54.
21.  Fourney DR, Schomer DF, Nader R, Chlan-Fourney J, Suki D, 
Ahrar K, et al. Percutaneous vertebroplasty and kyphoplasty for 
painful vertebral body fractures in cancer patients. J Neurosurg. 
2003 Jan;98(1 Suppl):21-30.
22.  Mendel E, Bourekas E, Gerszten P, Golan JD. Percutaneous 
techniques in the treatment of spine tumors: what are the diag-
nostic and therapeutic indications and outcomes? Spine (Phila 
Pa 1976). [Review]. 2009 Oct 15;34(22 Suppl):S93-100. doi: 
10.1097/BRS.0b013e3181b77895
Sažetak
KIRURŠKO LIJEČENJE METASTAZA KRALJEŽNICE 
M. Franić, V. Bilić, S. Dokuzović, S. Ćurić, T. Čengić i K. Rotim
Metastatska bolest kralježnice je dosta učestala i zasigurno zaslužuje pozornost i liječenje zbog visoke vjerojatnosti da bi 
inače bolesnici s karcinomom ostali oduzeti u svojim posljednjim mjesecima života. Novija postignuća i shvaćanja ponašanja 
raznih tipova tumora te unaprjeđenja u kirurškim tehnikama omogućuju evoluciju algoritama, pogotovo kada se kirurško 
liječenje razmatra. Ovaj rad daje pregled postupka donošenja odluka i ističe razne kirurške mogućnosti koje su trenutno 
dostupne.
Ključne riječi: Kralježnica – kirurgija; Kralježnica – patologija; Kralježnica, tumori, sekundarni; Metastaze – kirurgija; Pali-
jativna skrb – metode; Algoritmi; Odlučivanje, tehnike potpore
